SUN Pharmaceutical Industries Limited Dextromethorphan Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Dextromethorphan Export Records India — #1 Exporter, 63 Shipments, $1.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Dextromethorphan

India Pharmaceutical Trade Intelligence

$14.9M233 Suppliers94 CountriesHS 30049099

ExportsIndia → UNITED STATES26.3%India → PERU11.3%

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: BONAPHARM S.A.C

SUN Pharmaceutical Industries Limited — Dextromethorphan Exporter #1 | $1.3M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Dextromethorphan Exporter Profile

Indian Pharmaceutical Exporter · #1 for Dextromethorphan · $1.3M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #1 Indian exporter of Dextromethorphan with $1.3M in export value and 63 verified shipments. SUN Pharmaceutical Industries Limited holds a 8.9% market share in Dextromethorphan exports across 5 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Dextromethorphan Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Dextromethorphan export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Dextromethorphan?

Country	Value	Shipments	Share
MYANMAR	$829.6K	36	64.1%
FRANCE	$234.2K	19	18.1%
UNITED STATES	$149.3K	3	11.5%
ZAMBIA	$66.4K	3	5.1%

Who Are the Top Buyers of Dextromethorphan from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
M/S	MYANMAR	$524.3K	26
PLANET PHARMA	FRANCE	$234.2K	19
JDS CO., LTD	MYANMAR	$152.9K	5
OHM LABORATORIES INC.	UNITED STATES	$149.3K	3
JDS CO LIMITED	MYANMAR	$91.8K	3
TO JDS CO LTD	MYANMAR	$60.6K	2
MELCOME PHARMACEUTICALS LIMITED	ZAMBIA	$45.0K	1
STANDARD BANK MALAWI LTD	MALAWI	$14.2K	2
FIRST NATIONAL BANK	ZAMBIA	$13.3K	1
M/S. MELCOME PHARMACEUTICALS LIMITE	ZAMBIA	$8.2K	1

SUN Pharmaceutical Industries Limited supplies Dextromethorphan to 10 buyers globally. The largest buyer is M/S (MYANMAR), followed by PLANET PHARMA (FRANCE) and JDS CO., LTD (MYANMAR). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Dextromethorphan Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
CHERICOF COUGH FORMULA EACH 5ML CONTAINS: CHLORPHENIRAMINE MALEATE USP 2 MG, DEXTROMETHORPHAN HYDROBROMIDE USP 10 MG, PH	$677.2K	31
Guaifenesin & Dextromethorphan HBR ER Tablet 1200/60 mg PACK : 14s Strip Batch :MHF0083B/MHF0095A/MHF0106A/MHF0129A/MHF	$149.3K	3
CHERICOF SYRUP EACH 5ML CONTAINS CHLORPHENIRAMINE MALEATE USP 2MG DEXTROMETHORPHAN HYDROBROMIDE USP 10MG PHENYLPROPANOLA	$138.6K	7
CHERICOF COUGH FORMULA EACH 5ML CONTAINS:CHLORPHENIRAMINE MALEATE USP 2 MG DEXTROMETHORPHAN HYDROBROMIDE USP 10 MG PHE	$91.8K	3
CHERICOF COUGH FORMULA EACH 5ML CONTAINS CHLORPHENIRAMINE MALEATE USP 2 MG DEXTROMETHORPHAN HYDROBROMIDE USP 10 MG PHE	$60.6K	2
CHERICOF SYRUP 100ML EACH 5ML CONTAINS:CHLORPHENIRAMINE MALEATE USP 2MG, DEXTROMETHORPHAN HYDROBROMIDE USP 10MG,PHENYLP	$45.0K	1
CHERICOF SYRUP EACH 5ML CONTAINS CHLORPHENIRAMINE MALEATE USP 2MG DEXTROMETHORPHAN HYDROBROMIDE USP 10MG PHENYLPROPA	$43.9K	5
CHERICOF SYRUP EACH 5ML CONTAINS: CHLORPHENIRAMINE MALEATE USP 2MG, DEXTROMETHORPHAN HYDROBROMIDE USP 10MG,PHENYLPROPANO	$40.2K	4
CHERICOF SYRUP EACH 5ML CONTAINS: CHLORPHENIRAMINE MALEATE USP 2MG, DEXTROMETHORPHAN HYDROBROMIDE USP 10MG,PHENYLPROPAN	$17.9K	3
CHERICOF SYRUP 100ML EACH 5ML CONTAINS CHLORPHENIRAMINE MALEATE USP 2MG DEXTROMETHORPHAN HYDROBROMIDE USP 10MG PHENYLP	$13.3K	1

SUN Pharmaceutical Industries Limited exports 13 distinct Dextromethorphan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CHERICOF COUGH FORMULA EACH 5ML CONTAINS: CHLORPHENIRAMINE M with 31 shipments worth $677.2K.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Dextromethorphan Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$1.3M	63	5	$21.0K
2	SOFTGEL HEALTHCARE PRIVATE LIMITED	$1.1M	22	2	$50.0K
3	ELYSIUM PHARMACEUTICALS LTD	$1.1M	23	1	$47.8K

SUN Pharmaceutical Industries Limited ranks #1 among 233 Indian Dextromethorphan exporters. Average shipment value of $21.0K compared to the market average of $35.3K. The closest competitors by value are SOFTGEL HEALTHCARE PRIVATE LIMITED and ELYSIUM PHARMACEUTICALS LTD.

Which Indian Ports Ship Dextromethorphan Exports?

Port	Shipments	% Share
JNPT/ NHAVA SHEVA SEA	122	9.2%
NHAVA SHEVA SEA (INNSA1)	113	8.5%
JNPT	87	6.6%
SAHAR AIR CARGO ACC (INBOM4)	60	4.5%
CHENNAI SEA	56	4.2%
TUGLAKABAD ICD (INTKD6)	55	4.2%
MUNDRA SEA (INMUN1)	42	3.2%
BANGALORE ACC (INBLR4)	39	3.0%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Dextromethorphan Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Dextromethorphan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 63 individual customs records matching SUN Pharmaceutical Industries Limited exporting Dextromethorphan, covering 13 formulations to 5 countries via 10 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 94+ countries, 387+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Dextromethorphan

Dextromethorphan

SUN Pharmaceutical Industries Limited — Dextromethorphan Exporter Profile

SUN Pharmaceutical Industries Limited — Dextromethorphan Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Dextromethorphan?

Who Are the Top Buyers of Dextromethorphan from SUN Pharmaceutical Industries Limited?

What Is India's Total Dextromethorphan Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Dextromethorphan Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Dextromethorphan Exporters?

What Dextromethorphan Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Dextromethorphan to Key Markets

United States — FDA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Dextromethorphan Exporters?

Which Indian Ports Ship Dextromethorphan Exports?

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Dextromethorphan Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Dextromethorphan Export Data from SUN Pharmaceutical Industries Limited

Dextromethorphan Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source